A detailed history of Black Rock Inc. transactions in Rx Sight, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,400,464 shares of RXST stock, worth $80.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,400,464
Previous 2,109,559 13.79%
Holding current value
$80.8 Million
Previous $109 Million 32.74%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$50.42 - $64.29 $14.7 Million - $18.7 Million
290,905 Added 13.79%
2,400,464 $144 Million
Q1 2024

May 10, 2024

BUY
$35.51 - $57.92 $1.17 Million - $1.92 Million
33,089 Added 1.59%
2,109,559 $109 Million
Q4 2023

Feb 13, 2024

BUY
$20.91 - $40.9 $4.67 Million - $9.14 Million
223,381 Added 12.05%
2,076,470 $83.7 Million
Q3 2023

Nov 13, 2023

BUY
$27.05 - $33.37 $6.04 Million - $7.45 Million
223,161 Added 13.69%
1,853,089 $51.7 Million
Q2 2023

Aug 11, 2023

BUY
$16.37 - $28.9 $6.26 Million - $11 Million
382,119 Added 30.62%
1,629,928 $46.9 Million
Q1 2023

May 12, 2023

BUY
$12.58 - $16.68 $2.8 Million - $3.72 Million
222,907 Added 21.75%
1,247,809 $20.8 Million
Q4 2022

Feb 13, 2023

BUY
$9.93 - $14.2 $397,557 - $568,511
40,036 Added 4.07%
1,024,902 $13 Million
Q3 2022

Nov 14, 2022

BUY
$11.19 - $15.85 $473,627 - $670,867
42,326 Added 4.49%
984,866 $11.8 Million
Q2 2022

Aug 12, 2022

BUY
$10.61 - $16.66 $2.2 Million - $3.45 Million
206,951 Added 28.13%
942,540 $13.3 Million
Q1 2022

May 12, 2022

BUY
$8.97 - $14.03 $3.05 Million - $4.77 Million
340,091 Added 85.99%
735,589 $9.11 Million
Q4 2021

Feb 10, 2022

BUY
$9.52 - $13.81 $435,511 - $631,766
45,747 Added 13.08%
395,498 $4.45 Million
Q3 2021

Nov 09, 2021

BUY
$11.85 - $17.32 $4.14 Million - $6.06 Million
349,751 New
349,751 $4.43 Million

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $930M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.